By clicking “Subscribe” you agree to our Terms and Conditions and Privacy Policy.
NAD+ therapy has emerged as one of the most promising interventions in longevity medicine. But once you’ve decided to pursue NAD+ therapy, a practical question arises: how should you take it?
Luvo’s longevity program is one of the few that offers three distinct NAD+ delivery options — injection, oral liquid drops, and nasal spray. Each method has different absorption characteristics, convenience factors, and potential advantages. This guide helps you understand the differences so you can make an informed choice with your Luvo provider.
NAD+ injection delivers the molecule directly into your body via subcutaneous or intramuscular injection, bypassing the digestive system entirely.
Bioavailability is the standout advantage. Because the NAD+ enters your system without passing through the GI tract or liver first-pass metabolism, a much higher percentage of the administered dose reaches your cells. This makes injection the most efficient delivery method in terms of dose-to-effect ratio.
Injections are typically administered on a set schedule — often 2-3 times per week depending on your protocol. Many patients report the most pronounced and rapid effects with injectable NAD+, including noticeable energy improvements and mental clarity within the first week.
The trade-off is that injections require comfort with self-administration (though the needles are very small) and proper storage of the medication. For patients who want the highest-impact NAD+ delivery and don’t mind the injection process, this is often the preferred choice.
Explore Luvo’s NAD+ injection option for full details.
NAD+ oral liquid drops are designed for sublingual administration — placed under the tongue and held for 30-60 seconds before swallowing. This route allows a portion of the NAD+ to absorb directly through the mucous membranes of the mouth into the bloodstream.
Sublingual absorption partially bypasses digestive degradation, offering better bioavailability than standard oral capsules or tablets. The liquid formulation is also easier to dose precisely and absorb than solid supplements.
The primary advantage is convenience and ease of use. There are no needles, no special storage requirements beyond basic guidelines, and the drops can be taken anywhere as part of a daily routine. This makes oral drops particularly appealing for patients who are new to NAD+ therapy or prefer a gentler introduction.
Bioavailability is moderate compared to injection — some NAD+ is still lost to digestive processes. However, consistent daily dosing can build and maintain meaningful NAD+ levels over time.
Learn more about Luvo’s NAD+ oral liquid drops.
NAD+ nasal spray delivers the molecule through the nasal mucosa — the thin, highly vascularized tissue lining the nasal passages. This route offers rapid absorption into the bloodstream and a unique potential advantage: proximity to the brain.
The nasal cavity is separated from the brain by the cribriform plate, a thin bony structure that allows some molecules delivered intranasally to reach the central nervous system more directly than other delivery routes. While research on intranasal NAD+ specifically is still developing, the theoretical advantage for cognitive benefits — including improved focus, mental clarity, and neuroprotection — makes this an exciting option for patients whose primary concern is brain health.
Nasal spray is also needle-free and quick to administer, making it a practical choice for daily use. Most patients find it straightforward after the first few uses.
The bioavailability of nasal delivery falls between injection and oral drops, offering a solid middle ground for patients who want better absorption than oral but prefer to avoid injections.
Explore Luvo’s NAD+ nasal spray for more details.
The right choice depends on your priorities.
If maximum potency and fastest results are your priority, NAD+ injection is the clear leader. It delivers the most NAD+ per dose and produces the most pronounced effects. Choose this if you’re comfortable with needles and want the strongest intervention.
If convenience and simplicity matter most, NAD+ oral liquid drops fit seamlessly into any daily routine. They’re the easiest to start with and require no special technique. Choose this if you want a low-friction daily habit.
If cognitive function and brain health are your focus, NAD+ nasal spray offers a compelling combination of ease and potential neuro-specific benefits. Choose this if mental clarity, focus, and brain longevity are top priorities.
If you want comprehensive coverage, some patients in Luvo’s longevity program use a combination of delivery methods — for example, injections twice weekly supplemented by daily nasal spray. Your provider can help design a protocol that maximizes benefit for your specific goals.
Visit Luvo’s longevity program to discuss your options with a provider, or explore each option individually: NAD+ injection, NAD+ oral liquid drops, and NAD+ nasal spray.
Starting around age 30, your body’s production of growth hormone begins a steady decline — roughly 14% per decade. By the time you’re 60, you may be producing a fraction of the growth hormone you made in your twenties. This isn’t a disease. It’s a natural part of aging. But the consequences are far-reaching.
Growth hormone isn’t just about growth. In adults, it plays critical roles in maintaining muscle mass, regulating body fat distribution, supporting bone density, and sustaining energy and recovery. When levels decline, you experience what many people simply accept as “getting old” — increased belly fat, muscle wasting, slower recovery, poor sleep, and declining vitality.
Sermorelin offers a way to address this decline naturally, and it’s a cornerstone of Luvo’s longevity program.
Sermorelin is a growth hormone-releasing hormone (GHRH) analog — a synthetic version of the first 29 amino acids of the naturally occurring GHRH your hypothalamus produces. When administered, it stimulates your pituitary gland to release more of its own growth hormone.
This mechanism is fundamentally different from synthetic human growth hormone (HGH) injections, which introduce external growth hormone directly into your body. With Sermorelin, you’re not replacing your natural growth hormone — you’re reactivating your body’s own production system.
This distinction matters for several reasons. Sermorelin preserves the natural pulsatile pattern of growth hormone release, which is how the body is designed to use it. It works with your body’s feedback loops rather than overriding them, reducing the risk of excess. And because the pituitary maintains control, the risk of supraphysiological (above-normal) growth hormone levels is significantly lower than with direct HGH injection.
Synthetic HGH therapy has been available for decades, but it carries significant concerns that make it poorly suited for longevity use. Direct HGH injection bypasses the body’s regulatory mechanisms. This can lead to side effects including joint pain, carpal tunnel syndrome, insulin resistance, and potential concerns about accelerated growth of abnormal cells.
HGH also has regulatory and legal complexity. It’s a controlled substance with strict prescribing criteria, and its use for “anti-aging” purposes exists in a legal gray area.
Sermorelin avoids these issues. Because it works through your pituitary gland, growth hormone release is self-regulated — your body produces what it needs, not an arbitrary external amount. Side effects are generally mild and uncommon. And Sermorelin is legally prescribed for growth hormone optimization without the regulatory concerns of HGH.
Competitors may offer basic peptide access, but Luvo’s program integrates Sermorelin into a comprehensive longevity protocol with clinical oversight, dosing optimization, and complementary therapies like NAD+ and B12/MIC.
The clinical and patient-reported benefits of Sermorelin therapy address many of the most frustrating aspects of aging.
Improved body composition is one of the most noticeable effects. Growth hormone plays a direct role in fat metabolism and muscle maintenance. Patients on Sermorelin commonly report reduced abdominal fat and improved muscle tone, even without dramatic changes to their exercise routine.
Better overall recovery is another commonly reported benefit. Growth hormone is primarily released during deep sleep, and Sermorelin helps restore this natural hormonal pattern. Individual results vary based on baseline hormone levels and overall health.
Enhanced recovery is commonly reported by patients on Sermorelin therapy. Growth hormone plays a role in the body's natural recovery processes, and restoring healthy levels may support overall wellbeing. Individual results vary.
Stronger immune function, improved skin elasticity, and better cognitive clarity are also commonly reported, though individual results vary based on baseline growth hormone levels and overall health.
Sermorelin is administered via subcutaneous injection, typically in the evening to align with the body’s natural growth hormone release cycle during sleep. Most patients adapt to the injection process quickly — the needle is small and the injection is virtually painless.
Results develop gradually. Most patients notice improvements in energy within the first 2-4 weeks. Body composition changes and recovery improvements typically become apparent over 2-3 months. The full benefits of Sermorelin therapy continue to develop over 3-6 months of consistent use.
Your Luvo provider will establish your starting dose based on your health profile and goals, then monitor your progress with regular check-ins. Dose adjustments are made based on your clinical response and, when indicated, lab work to track growth hormone and IGF-1 levels.
Learn more about Sermorelin through Luvo’s program, or explore how it works alongside our other longevity therapies including NAD+ and Vitamin B12/MIC.
If you’ve spent any time reading about longevity science, you’ve encountered NAD+. It’s arguably the most talked-about molecule in the aging research community — and for good reason. NAD+ (nicotinamide adenine dinucleotide) is involved in hundreds of metabolic reactions in every cell of your body. Without adequate NAD+, your cells can’t produce energy efficiently, repair damaged DNA, or activate the protective pathways that keep aging in check.
The problem is that NAD+ levels plummet as you age. By middle age, most people have roughly half the NAD+ they had in their twenties. This decline is now understood to be a key driver of age-related disease and functional deterioration — not just a consequence of it.
Luvo’s longevity program offers NAD+ therapy in three distinct delivery formats, giving patients flexibility to choose the method that fits their lifestyle and goals.
NAD+ is a coenzyme — a molecule that helps enzymes do their jobs. It participates in two broad categories of biological processes that are critical for aging.
First, energy metabolism. NAD+ is essential for converting the food you eat into cellular energy (ATP) through the mitochondrial electron transport chain. When NAD+ levels drop, mitochondrial function declines, and you feel it as fatigue, brain fog, and reduced physical stamina.
Second, cellular maintenance and repair. NAD+ activates a family of proteins called sirtuins (SIRT1-7), often called the “longevity genes.” Sirtuins regulate DNA repair, inflammation, mitochondrial biogenesis, and cellular stress responses. They’re essentially your cells’ maintenance crew — and they can’t work without NAD+ as fuel.
NAD+ is also consumed by PARP enzymes during DNA repair. As DNA damage accumulates with age, more NAD+ is diverted to repair, leaving less available for energy production and sirtuin activation. This creates a vicious cycle: aging causes NAD+ depletion, and NAD+ depletion accelerates aging.
Walk into any supplement store and you’ll find NAD+ precursors like NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) marketed as longevity supplements. While these precursors can modestly raise NAD+ levels, they face significant limitations.
Bioavailability is a major issue. Oral NAD+ precursors must survive the digestive system, be absorbed, and then be converted through multiple enzymatic steps into active NAD+. Each step involves loss. The actual amount of NAD+ that reaches your cells is a fraction of what’s on the label.
Quality control is another concern. The supplement industry is loosely regulated compared to prescription medications. Testing has repeatedly found that many NAD+ supplements contain less active ingredient than claimed, or contain contaminants.
This is why Luvo offers clinical-grade NAD+ therapy in formulations designed for superior delivery — not the same over-the-counter products you can buy at a health food store. Our NAD+ options include pharmaceutical-grade injection, oral liquid drops, and nasal spray, each with distinct absorption characteristics.
Luvo’s longevity program offers three ways to receive NAD+ therapy, each with specific advantages.
NAD+ injection delivers NAD+ directly into the bloodstream or subcutaneous tissue, bypassing the digestive system entirely. This provides the highest bioavailability of any delivery method. Injections are ideal for patients who want maximum cellular impact and are comfortable with self-injection. Many patients report feeling noticeable improvements in energy and mental clarity within days of starting.
NAD+ oral liquid drops offer a convenient, needle-free option. The liquid formulation is designed for sublingual absorption — held under the tongue where it can enter the bloodstream through the mucous membranes, partially bypassing digestive degradation. This method suits patients who want daily dosing simplicity.
NAD+ nasal spray delivers NAD+ through the nasal mucosa, which provides rapid absorption and potential advantages for brain-related benefits due to the proximity of the nasal passages to the central nervous system. Some research suggests intranasal delivery may support cognitive function more directly than other routes.
Your Luvo provider can recommend the delivery method — or combination of methods — best suited to your goals, whether that’s maximum systemic NAD+ restoration, cognitive focus, or lifestyle convenience.
NAD+ therapy affects people differently depending on their baseline levels, age, and overall health. However, patients commonly report improved energy levels and reduced fatigue, sharper mental clarity and reduced brain fog, better sleep quality, faster recovery from exercise, improved mood and reduced feelings of sluggishness, and a general sense of vitality and well-being.
These benefits typically emerge within the first few weeks of consistent therapy and continue to develop over months. NAD+ therapy is most effective as part of an ongoing protocol rather than a one-time treatment — which is why Luvo’s longevity program is designed for sustained use.
Explore Luvo’s NAD+ options: NAD+ injection, NAD+ oral liquid drops, and NAD+ nasal spray.
The longevity conversation has exploded in recent years. Podcasts, bestselling books, and a growing community of researchers and biohackers have brought the science of aging into mainstream awareness. But beneath the hype, there’s a serious and rapidly evolving medical discipline focused on one central question: how do we extend not just lifespan, but healthspan — the number of years you live in good health, free from chronic disease and functional decline?
That’s the foundation of Luvo’s longevity program. It’s not about miracle cures or reversing the clock. It’s about using evidence-based therapies to support your body’s own repair and regeneration systems as they naturally slow down with age.
The wellness industry is flooded with products promising to “reverse aging.” Most of these claims are unsupported by clinical evidence. Longevity medicine is fundamentally different. It’s a clinical discipline rooted in the biology of aging — specifically, the molecular and cellular mechanisms that drive age-related decline.
Researchers have identified several hallmarks of aging: mitochondrial dysfunction, cellular senescence, epigenetic changes, loss of proteostasis, and declining levels of critical molecules like NAD+ and growth hormone. Longevity medicine targets these mechanisms directly, using therapies that have measurable biological effects — not just cosmetic ones.
Competitors in the telehealth space tend to focus on single-symptom treatments. Luvo’s longevity program takes a systems-level approach, combining multiple therapies that address different hallmarks of aging simultaneously.
Luvo’s longevity program is built around five medications, each targeting a different aspect of age-related decline.
Sermorelin is a growth hormone-releasing peptide that stimulates your pituitary gland to produce more of its own growth hormone. Growth hormone levels decline significantly with age, contributing to muscle loss, increased body fat, reduced bone density, and slower recovery. Sermorelin restores this signaling naturally.
NAD+ therapy is available in three delivery formats — injection, oral liquid drops, and nasal spray. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential for cellular energy production, DNA repair, and activation of sirtuins — the proteins that regulate aging at the cellular level. NAD+ levels decline by as much as 50% between ages 40 and 60.
Vitamin B12/MIC is a lipotropic injection combining Vitamin B12 with methionine, inositol, and choline. This combination supports energy metabolism, fat metabolism, liver function, and methylation — a biochemical process critical for DNA maintenance and detoxification.
Together, these therapies create a comprehensive protocol addressing energy production, hormonal optimization, cellular repair, and metabolic health.
Luvo’s longevity program is designed for adults who are proactive about their health — people who don’t want to wait until disease develops to take action. You might be a good candidate if you’re experiencing age-related fatigue, brain fog, or declining physical performance, if you’re interested in optimizing your healthspan based on the latest science, if you want clinical-grade therapies under medical supervision rather than over-the-counter supplements of questionable quality, or if you’re looking for a comprehensive approach rather than a single-product solution.
The program is available through Luvo’s telehealth platform, with licensed providers who specialize in longevity medicine and can tailor a protocol to your specific needs and goals.
Many competitors offer individual longevity-adjacent products — an NAD+ supplement here, a B12 shot there. What sets Luvo apart is the integrated program design. Our providers don’t just prescribe a single therapy; they assess your overall health profile and build a protocol that combines therapies for synergistic benefit.
Sermorelin supports the hormonal axis. NAD+ fuels cellular repair. B12/MIC optimizes metabolic pathways. Together, they work on multiple fronts — and that’s the kind of comprehensive approach that longevity science actually supports.
Explore Luvo’s full longevity program to learn more, or dive into our individual medication pages for Sermorelin, NAD+ injection, NAD+ oral drops, NAD+ nasal spray, and Vitamin B12/MIC.
For many men, the 40s are when the accumulation of declining testosterone becomes impossible to ignore. The symptoms that were subtle in your late 30s — a little more fatigue, a little less drive — become hard to dismiss by 42 or 45. The belly fat that resisted your best efforts, the gym sessions that stopped producing results, the libido that shifted from a priority to an afterthought, the mental sharpness that used to be effortless.
Here’s the good news: this is one of the most treatable conditions in medicine. Testosterone optimization in men over 40 is safe, effective, and increasingly well-supported by clinical evidence. And Luvo’s testosterone program is specifically designed to make it accessible, affordable, and clinically supervised.
By age 40, most men have experienced a 15–25% decline from their peak testosterone levels. By 50, that decline often reaches 30–40%. But the numbers only tell part of the story.
SHBG (sex hormone-binding globulin) tends to increase with age, binding more of your circulating testosterone and reducing the free testosterone available to your tissues. This means your total testosterone number may underestimate the actual deficiency your body is experiencing. A man with a total testosterone of 450 ng/dL but elevated SHBG may have the free testosterone equivalent of someone at 300 ng/dL.
Additionally, androgen receptor sensitivity may decline with age, meaning the same testosterone level produces less biological effect in a 50-year-old than a 30-year-old. Your tissues become less responsive to the hormone even as less of it is available.
The result is that men over 40 often feel the effects of testosterone decline more acutely than their numbers alone would suggest. This is why Luvo’s providers assess the full hormonal picture — total testosterone, free testosterone, SHBG, LH, FSH, and estradiol — rather than making decisions based on a single number.
A persistent myth in some medical circles holds that testosterone therapy in older men is unnecessary or risky. Neither claim holds up under current evidence.
The TRAVERSE trial, published in the New England Journal of Medicine, studied over 5,000 men aged 45–80 with hypogonadism and pre-existing cardiovascular disease or high cardiovascular risk. The study found no increased cardiovascular risk with testosterone therapy — directly contradicting the fears that kept many providers from prescribing TRT to older men.
The Testosterone Trials (TTrials), a coordinated set of seven randomized controlled trials in men over 65, demonstrated that testosterone therapy improved sexual function, physical function (walking distance), vitality, mood, and bone density. These benefits were consistent and clinically meaningful.
The evidence is clear: age alone is not a contraindication to testosterone optimization. What matters is whether you have a documented deficiency, whether you have symptoms that affect your quality of life, and whether appropriate screening and monitoring are in place.
Luvo’s program provides all three. Competitors that turn away men over 40 or 50 are operating on outdated science.
While the benefits of testosterone optimization apply across age groups, men over 40 may have specific considerations that influence treatment planning.
Fertility priorities shift for many men over 40, but not all. Some men in their 40s and even 50s are starting new families. Luvo’s availability of Enclomiphene and Gonadorelin ensures that fertility preservation remains an option regardless of age.
Prostate health monitoring becomes more important. While testosterone therapy does not cause prostate cancer, pre-existing prostate conditions should be evaluated before starting treatment. Luvo’s protocol includes baseline PSA testing and regular monitoring.
Cardiovascular risk factors are more prevalent in men over 40. Luvo’s providers screen for hypertension, dyslipidemia, and other cardiovascular risk factors, monitoring hematocrit and cardiovascular markers throughout treatment.
Medication interactions become more likely as men accumulate prescriptions for other conditions. Luvo’s clinical team reviews all current medications to avoid interactions and optimize the treatment plan.
Sleep apnea screening is important because testosterone therapy can theoretically worsen untreated obstructive sleep apnea. If sleep apnea is suspected, your Luvo provider will recommend evaluation before or alongside testosterone optimization.
Luvo’s testosterone program is designed for the complexity that men over 40 bring to the table. Rather than a simplified, one-size-fits-all protocol, our providers create individualized treatment plans that account for your full health picture.
The process starts with a comprehensive health assessment and bloodwork review. Your provider will determine whether TRT, Enclomiphene, Gonadorelin, or a combination is the right approach for your hormonal profile, symptoms, and goals.
Ongoing monitoring ensures your treatment stays safe and effective over time, with dose adjustments and protocol refinements based on your response. This isn’t a set-it-and-forget-it prescription — it’s an evolving clinical relationship designed to keep you at your best.
The men who thrive on Luvo’s program are those who approach it as a long-term investment in their health — not a quick fix. And the results — more energy, better body composition, sharper thinking, stronger libido, and improved mood — are well worth the investment.
Explore Luvo’s testosterone program to get started, or learn about our medication options: testosterone medication, Enclomiphene, and Gonadorelin.
Search for “testosterone therapy side effects” and you’ll encounter a wide range of claims — from mild concerns to terrifying warnings. Some are legitimate risks that require careful management. Others are outdated myths that persist despite the evidence. And a few fall somewhere in between.
For men considering Luvo’s testosterone program, understanding the actual risk landscape — not the fear-based version — is essential for making an informed decision. This article provides an honest, evidence-based assessment of what the risks really are and how Luvo’s clinical approach minimizes them.
Several side effects are well-documented with testosterone therapy. None are reasons to avoid treatment, but all require monitoring and management.
Erythrocytosis (elevated hematocrit) is the most common measurable side effect. Testosterone stimulates erythropoietin production, increasing red blood cell mass. While mildly elevated hematocrit may be benign, significant elevation increases blood viscosity and theoretically raises cardiovascular risk. Luvo monitors hematocrit through regular bloodwork. If levels rise above the target range, dose adjustments or therapeutic phlebotomy (blood donation) are recommended.
Testicular atrophy and fertility suppression are expected physiological consequences of exogenous testosterone, not side effects per se. When the body receives testosterone externally, it reduces its own production, causing the testes to shrink and sperm production to decline. Luvo addresses this proactively with Gonadorelin, which maintains testicular stimulation alongside TRT.
Estrogen-related effects can occur as testosterone is partially converted to estradiol by aromatase. Elevated estradiol can cause water retention, mood changes, nipple sensitivity, and in rare cases, gynecomastia (breast tissue growth). Luvo monitors estradiol levels and adjusts protocols to keep the testosterone-to-estradiol ratio optimized.
Acne and oily skin affect some men, particularly in the early months of therapy, as androgen-sensitive sebaceous glands respond to increased testosterone. This is usually mild and self-limiting. Dose adjustments or simple skincare interventions typically resolve it.
Several “risks” of testosterone therapy have been significantly overstated by media coverage and outdated medical attitudes.
Cardiovascular risk was the subject of several concerning headlines in the 2010s, based on flawed observational studies. Subsequent large-scale research, including the TRAVERSE trial (a randomized controlled trial of over 5,000 men), found no increased risk of major adverse cardiovascular events with testosterone therapy in men with hypogonadism and pre-existing cardiovascular risk factors. The current evidence consensus is that testosterone therapy at physiological replacement doses does not increase cardiovascular risk and may actually improve cardiovascular risk factors through improvements in body composition, insulin sensitivity, and inflammatory markers.
Prostate cancer is perhaps the most persistent myth. The idea that testosterone “feeds” prostate cancer originated from a 1941 case report and was never supported by subsequent evidence. Multiple large studies have found no increased risk of prostate cancer with testosterone therapy. Current evidence suggests that testosterone therapy is safe in men without existing prostate cancer, and even men treated for prostate cancer may be candidates for testosterone therapy under appropriate surveillance. Luvo monitors PSA levels as a standard part of its protocol.
Liver damage is a risk associated with oral methylated testosterone (17-alpha-alkylated testosterone), which is not used in modern TRT protocols. Injectable and transdermal testosterone do not undergo first-pass hepatic metabolism and are not associated with liver toxicity.
The side-effect experience with testosterone therapy is highly individual. Genetics, baseline health, body composition, dose, and delivery method all influence how a given man responds to treatment.
Some men experience virtually no side effects at therapeutic doses. Others may need frequent protocol adjustments to find the balance between optimal testosterone levels and manageable side effects. A man with high aromatase activity (often correlated with higher body fat) may convert more testosterone to estrogen, requiring monitoring and potentially adjunctive treatment. A man with naturally high hematocrit may reach concerning levels more quickly.
This variability is precisely why Luvo’s monitoring protocol exists. Regular bloodwork, symptom tracking, and provider communication allow for real-time adjustments that keep you in the optimal zone — maximum benefit with minimum side effects.
Competitors that offer TRT with minimal follow-up — a prescription and a phone number — leave you to navigate these variables alone. Luvo’s program treats monitoring as a core service, not an add-on.
The availability of Enclomiphene and Gonadorelin alongside testosterone medication isn’t just about treatment flexibility — it’s about risk reduction.
Gonadorelin mitigates the fertility and testicular suppression risk of TRT, eliminating one of the most significant concerns for younger men. Without Gonadorelin, fertility preservation on TRT is essentially impossible. With it, men can enjoy the full benefits of testosterone optimization while maintaining reproductive potential.
Enclomiphene offers a risk pathway entirely different from TRT. Because it stimulates endogenous production rather than introducing exogenous hormone, the risks of erythrocytosis and estrogen excess are lower. For men who can achieve adequate testosterone elevation with Enclomiphene, it may represent the lowest-risk treatment option.
The ability to combine, switch between, and adjust these three medications gives Luvo’s providers a toolkit for minimizing risk while maximizing results. It’s a more sophisticated approach than the TRT-only model that dominates the market.
Learn more about Luvo’s comprehensive testosterone program, including testosterone medication, Enclomiphene, and Gonadorelin.
You’re hitting the gym regularly. Your diet is reasonable. But the mirror tells a frustrating story: more belly fat, less muscle definition, and a physique that seems to be moving in the wrong direction despite your best efforts.
Before you blame your workout program or your willpower, consider this: testosterone is one of the most powerful regulators of body composition in the male body, and if your levels have declined, no amount of exercise can fully compensate. The relationship between testosterone and body composition is direct, dose-dependent, and well-documented — and it’s one of the most compelling reasons men seek testosterone optimization.
Testosterone drives muscle growth through several interconnected mechanisms.
Protein synthesis acceleration is the most direct effect. Testosterone binds to androgen receptors in muscle cells and activates genes responsible for muscle protein synthesis — the process of building new muscle tissue from dietary amino acids. With adequate testosterone, muscles build and repair themselves more efficiently after exercise. With low testosterone, the same workout produces less muscle growth because the anabolic signal is weaker.
Satellite cell activation is another important mechanism. Satellite cells are muscle stem cells that fuse with existing muscle fibers to support growth and repair. Testosterone increases both the number and activity of satellite cells, enhancing the muscle’s capacity for hypertrophy.
Anti-catabolic effects mean testosterone also protects existing muscle from breakdown. Cortisol, the primary stress hormone, promotes muscle protein breakdown. Testosterone counterbalances cortisol’s catabolic effects, shifting the body toward net protein synthesis rather than net protein breakdown.
Myostatin modulation is a more recently understood mechanism. Myostatin is a protein that limits muscle growth. Testosterone suppresses myostatin expression, effectively removing a brake on muscle development.
When testosterone declines, all of these mechanisms weaken simultaneously. The result is progressive sarcopenia — age-related muscle loss — that accelerates as hormone levels fall further.
Testosterone’s effects on body fat are equally significant and help explain the “middle-age spread” that many men experience.
Lipolysis promotion is a key function. Testosterone promotes the breakdown of stored fat for energy, particularly visceral fat — the metabolically dangerous fat stored around the abdominal organs. Adequate testosterone levels keep this fat mobilization active; low levels allow fat to accumulate unchecked.
Adipocyte regulation means testosterone influences how fat cells develop and behave. It inhibits the differentiation of new fat cells (adipogenesis) and reduces the size of existing fat cells. When testosterone drops, the body creates more fat cells and fills existing ones more readily.
The aromatase cycle creates a particularly vicious feedback loop. Fat tissue contains aromatase, the enzyme that converts testosterone to estrogen. As a man gains fat, more testosterone is converted to estrogen, further reducing available testosterone and making additional fat gain even more likely. This testosterone-fat spiral can be very difficult to break without hormonal intervention.
Insulin sensitivity is also affected. Testosterone improves insulin sensitivity, while low testosterone promotes insulin resistance. Insulin resistance shifts metabolic fuel partitioning toward fat storage and away from muscle, compounding the body composition problem.
The research is extensive and consistent.
A landmark meta-analysis published in Clinical Endocrinology reviewed 37 randomized controlled trials and found that testosterone therapy produced an average reduction in fat mass of 1.6 kg (3.5 pounds) and an increase in lean mass of 1.6 kg — essentially a body recomposition effect. These results occurred without mandated changes to diet or exercise.
Longer-duration studies show even more impressive results. A 10-year observational study of men on TRT showed sustained reductions in waist circumference, BMI, and body weight, with improvements continuing over the full study period. Men who discontinued TRT regained the weight.
The effects are amplified by exercise. When TRT is combined with resistance training, muscle gains are significantly greater than with either intervention alone. Testosterone provides the anabolic environment, and exercise provides the stimulus — together, they produce results that neither can achieve independently.
Luvo’s program approaches body composition from the hormonal foundation up.
For men with significantly low testosterone, TRT provides the most robust hormonal correction, creating the anabolic environment needed for meaningful body recomposition. Combined with Gonadorelin to maintain testicular function, this approach delivers full testosterone optimization safely.
For men with moderate deficiency or who prefer a conservative approach, Enclomiphene can raise testosterone sufficiently to improve the anabolic-catabolic balance, support fat loss, and enhance the response to exercise.
Regardless of the medication approach, Luvo’s providers emphasize that hormone optimization works best alongside a training program that includes progressive resistance exercise and nutrition that provides adequate protein (at least 0.7g per pound of bodyweight). Testosterone creates the conditions for change; lifestyle provides the stimulus.
Expect body composition improvements to develop over 3–6 months, with continued refinement over 12 months. The changes are real, measurable, and sustainable as long as testosterone remains optimized.
Explore Luvo’s full testosterone program, including testosterone medication, Enclomiphene, and Gonadorelin.
Most men who seek testosterone optimization know one thing: their T is low and they want it higher. That’s a reasonable starting point, but the how of raising testosterone matters enormously. Different treatments work on different parts of the hormonal system, with different consequences for fertility, long-term health, and treatment sustainability.
Understanding the hypothalamic-pituitary-gonadal (HPG) axis — the system that controls testosterone production — is the key to understanding why Luvo offers three distinct medications and why the right choice depends on where your system is failing.
Testosterone production is controlled by a three-level signaling cascade.
Level one is the hypothalamus. This brain structure produces gonadotropin-releasing hormone (GnRH) in a pulsatile pattern — roughly every 60–90 minutes. The pulsatile nature of GnRH release is critical; continuous GnRH exposure actually suppresses the pituitary rather than stimulating it.
Level two is the anterior pituitary gland. In response to pulsatile GnRH, the pituitary releases two gonadotropins: luteinizing hormone (LH), which stimulates the Leydig cells in the testes to produce testosterone, and follicle-stimulating hormone (FSH), which stimulates the Sertoli cells to support sperm production.
Level three is the testes. Leydig cells receive the LH signal and synthesize testosterone from cholesterol through a series of enzymatic conversions. The testosterone enters the bloodstream and exerts its effects throughout the body. Sertoli cells, stimulated by FSH, create the environment necessary for spermatogenesis.
The system is regulated by negative feedback: testosterone (and its metabolite estradiol) signal back to the hypothalamus and pituitary, modulating GnRH, LH, and FSH output to maintain homeostasis. When the system works properly, testosterone levels are maintained within a functional range.
Low testosterone can result from failure at different levels of the HPG axis, and identifying where the problem lies is essential for choosing the right treatment.
Primary hypogonadism means the testes themselves are failing. Despite adequate LH and FSH signaling, the Leydig cells can’t produce sufficient testosterone. In this case, LH and FSH levels are elevated (the pituitary is working harder to compensate) while testosterone remains low. Causes include testicular injury, genetic conditions like Klinefelter syndrome, and age-related Leydig cell decline.
Secondary hypogonadism means the problem is upstream — the hypothalamus or pituitary isn’t sending adequate signals. LH and FSH levels are low or inappropriately normal, and the testes aren’t being stimulated to produce testosterone. This is the more common pattern in age-related testosterone decline, obesity-related low T, and stress-induced hormonal suppression.
Mixed hypogonadism involves dysfunction at multiple levels — both reduced signaling and reduced testicular response. This is increasingly common in older men.
Luvo’s providers use comprehensive bloodwork to identify which pattern is present, because the answer directly determines the optimal treatment strategy.
Each medication in Luvo’s testosterone program intervenes at a different point in the HPG axis, which is why having all three available is a clinical advantage.
Testosterone medication works at the end of the chain, directly replacing the hormone the testes aren’t producing enough of. It’s the most direct and potent approach — it reliably raises testosterone regardless of where the system is failing. The trade-off is that exogenous testosterone suppresses the upstream signaling (GnRH, LH, FSH), leading to testicular suppression.
Enclomiphene works at the top of the chain, at the hypothalamic level. By blocking estrogen’s negative feedback, it increases GnRH output, which increases LH and FSH, which stimulates the testes to produce more testosterone naturally. This preserves the entire axis but depends on the testes being capable of responding to increased stimulation.
Gonadorelin works at the middle of the chain, directly stimulating the pituitary to release LH and FSH. It’s most valuable as an adjunct to TRT, replacing the GnRH signal that exogenous testosterone suppresses and maintaining testicular function during testosterone replacement.
This three-level approach is what makes Luvo’s program unique. Rather than offering one solution for every patient, we match the intervention to the level of the HPG axis where it’s most needed. Explore all three options: testosterone medication, Enclomiphene, and Gonadorelin.
When a telehealth clinic offers only TRT with no alternatives, they’re giving every man the same tool regardless of where his system is failing. A man with secondary hypogonadism (a signaling problem) might respond beautifully to Enclomiphene, preserving his fertility and maintaining a functional HPG axis — but if TRT is the only option, he’ll get exogenous testosterone and all the suppressive effects that come with it.
Conversely, a man with primary hypogonadism won’t respond well to Enclomiphene because his testes can’t increase production even with more LH stimulation. He needs testosterone replacement, ideally with Gonadorelin to preserve what testicular function remains.
Luvo’s diagnostic approach identifies which scenario applies to you, and our three-medication toolkit ensures you get the treatment that matches your physiology — not just the treatment that’s easiest to prescribe.
Visit Luvo’s testosterone program to start with a comprehensive hormonal evaluation.
Low testosterone doesn’t announce itself with a single dramatic symptom. It creeps in gradually — a little less energy here, a few extra pounds there, a subtle shift in mood that you can’t quite explain. Most men don’t connect these changes to a hormonal issue because each symptom, in isolation, seems explainable by something else: stress, age, a busy schedule, not enough sleep.
But when multiple symptoms appear together and persist over months, the pattern often points to declining testosterone. This checklist will help you recognize that pattern and decide whether it’s time to get your levels checked.
Low testosterone profoundly affects energy metabolism and overall vitality. Watch for these signs.
Persistent fatigue that doesn’t improve with rest is one of the earliest and most universal complaints among men with low T. This isn’t normal tiredness from a long day — it’s a deep, pervasive lack of energy that sleep doesn’t resolve. You may find yourself relying increasingly on caffeine just to function at baseline.
Decreased motivation and drive extends beyond physical energy into psychological territory. Tasks that used to excite you feel like obligations. Projects stall. The ambition that defined your earlier years feels like a distant memory. This is often mistakenly attributed to burnout or depression, but testosterone’s role in dopaminergic motivation circuits means low T can directly dampen your drive.
Afternoon crashes become more pronounced and frequent. Where you used to power through the afternoon, you now hit a wall around 2-3 PM that makes concentration nearly impossible.
If these resonate, declining testosterone may be contributing. Luvo’s testosterone program can evaluate your levels and determine whether hormonal optimization could restore the energy you’ve lost.
Testosterone is one of the primary regulators of body composition in men. When it declines, the changes are visible.
Increased abdominal fat despite consistent eating habits is a hallmark of low T. Testosterone inhibits fat storage and promotes fat metabolism; as levels drop, the body shifts toward fat accumulation, particularly visceral fat around the midsection. Many men describe doing everything right with diet and exercise but still gaining belly fat.
Loss of muscle mass or difficulty building muscle is another clear signal. Testosterone drives protein synthesis in muscle tissue. Without adequate T, muscles atrophy more quickly, recovery from resistance training is slower, and gains from exercise become frustratingly elusive.
Decreased physical endurance and strength manifest as workouts feeling harder than they should, weights feeling heavier, and cardiovascular endurance declining without explanation. Testosterone supports red blood cell production (oxygen delivery) and mitochondrial function in muscle, so low T affects performance from multiple angles.
Testosterone’s effects on the brain are profound and often underappreciated.
Brain fog and cognitive slowing — difficulty finding words, reduced processing speed, trouble concentrating — affect many men with low T. Testosterone receptors are densely distributed in brain regions responsible for memory, attention, and executive function. When testosterone falls, cognitive performance can measurably decline.
Irritability and mood instability are common but frequently misattributed. Men with low T often describe a shorter fuse, disproportionate emotional reactions, or a persistent background irritability they can’t explain. This isn’t a personality change — it’s a neurochemical one.
Depressive symptoms including persistent low mood, anhedonia (inability to feel pleasure), and social withdrawal have strong associations with low testosterone. While low T isn’t the only cause of depression, it’s a treatable contributing factor that standard depression screening often misses.
Poor sleep quality rounds out the mental cluster. Testosterone influences sleep architecture, and low levels are associated with difficulty falling asleep, reduced deep sleep, and more frequent nighttime awakenings.
Sexual symptoms are often what finally prompt men to seek evaluation, though they’re rarely the first symptoms to appear.
Decreased libido — a reduced interest in sex that goes beyond normal fluctuations — is one of the most specific symptoms of low T. Testosterone directly drives sexual desire, and its decline produces a noticeable reduction in sexual thoughts, fantasies, and spontaneous arousal.
Erectile changes include difficulty achieving or maintaining erections, reduced firmness, and fewer morning erections. While ED has multiple potential causes, testosterone is essential for the neurological and vascular mechanisms that produce erections.
Reduced sexual satisfaction — the sense that sex is less pleasurable, less intense, or less fulfilling than before — is sometimes described even when function remains technically adequate.
If you recognize yourself in three or more symptoms across multiple clusters, it’s worth getting your testosterone levels checked. A simple blood test measuring total testosterone, free testosterone, SHBG, LH, and FSH can provide a clear picture of your hormonal status.
Don’t wait for symptoms to become severe. The earlier you address declining testosterone, the easier it is to optimize — and the sooner you regain the quality of life you’ve been gradually losing.
Luvo’s testosterone program starts with a comprehensive clinical evaluation, including bloodwork review by a provider who specializes in male hormone optimization. Based on your results and symptoms, your provider will recommend the right approach — whether that’s testosterone replacement, Enclomiphene, Gonadorelin, or a strategic combination.
Visit Luvo’s testosterone program to start your evaluation.
Here’s a scenario that plays out in men’s health clinics every day: a man in his early 30s has symptoms of low testosterone. He’s fatigued, his libido is low, he’s gaining weight. He gets bloodwork, confirms his T is low, and starts testosterone replacement therapy. He feels great.
Two years later, he and his partner start trying to have a baby. A semen analysis reveals his sperm count is near zero. He’s now facing months or years of recovery — and the possibility that his fertility may never fully return to pre-TRT levels.
This scenario is entirely preventable. The problem isn’t that TRT is dangerous — it’s that most TRT protocols ignore fertility preservation from the start. Luvo’s testosterone program is built differently, offering a range of approaches that let men optimize testosterone and protect reproductive function simultaneously.
Understanding the mechanism is critical for making informed treatment decisions.
Your hormonal system operates on feedback loops. The hypothalamus produces GnRH, which tells the pituitary to produce LH and FSH. LH stimulates the testes to produce testosterone. FSH stimulates the testes to produce sperm. When testosterone levels are sufficient, the hypothalamus reduces GnRH output, completing the feedback loop.
When you introduce exogenous testosterone, blood levels rise quickly to the target range. The hypothalamus detects this and dramatically reduces GnRH output. The pituitary, receiving little GnRH, stops producing meaningful amounts of LH and FSH. Without FSH, the Sertoli cells in the testes that support sperm development lose their stimulation. Sperm production can decline by 90% or more.
This isn’t a rare side effect — it’s the expected physiological response. It happens to virtually every man on TRT who doesn’t take steps to prevent it.
For men whose primary concern is preserving fertility while addressing low testosterone, Enclomiphene offers an elegant solution. By blocking estrogen feedback at the hypothalamus, Enclomiphene increases GnRH, LH, and FSH — stimulating both testosterone and sperm production simultaneously.
This approach is particularly attractive for men in their 20s and 30s who are actively trying to conceive or expect to in the near future, men with mild-to-moderate testosterone deficiency who may respond well to enhanced endogenous production, and men who want to try the most conservative approach first.
The limitation of Enclomiphene is that the degree of testosterone elevation may be less than what TRT provides. Men with very low baseline testosterone or primary testicular failure may not achieve sufficient improvement with Enclomiphene alone.
Luvo’s providers evaluate each man’s hormonal profile to determine whether Enclomiphene alone is likely to provide adequate testosterone optimization.
For men who need the more robust testosterone elevation that TRT provides but still want to protect fertility, the combination of testosterone medication and Gonadorelin is Luvo’s recommended approach.
TRT raises testosterone levels reliably and substantially, delivering the full range of symptomatic benefits. Gonadorelin, administered alongside TRT, replaces the GnRH signal that exogenous testosterone suppresses. This keeps the pituitary producing LH and FSH, maintaining testicular function and sperm production even in the presence of exogenous testosterone.
This combination provides the best of both worlds: optimal testosterone levels for symptom relief and quality of life, plus preserved reproductive capacity. It’s a protocol that requires more clinical sophistication to manage, which is why it’s not commonly offered by high-volume telehealth competitors that prioritize simplicity over optimization.
Some patients benefit from all three medications working together. In this approach, TRT provides the primary testosterone elevation. Gonadorelin maintains pituitary and testicular function. Enclomiphene provides additional endogenous stimulation and helps manage estrogen-related effects.
This triple protocol is the most comprehensive option in Luvo’s testosterone program and represents a level of hormonal optimization that few telehealth platforms offer. It’s typically reserved for men who want maximum testosterone optimization, need robust fertility preservation, benefit from the estrogen-modulating effects of Enclomiphene, and are comfortable with a multi-medication protocol.
Your Luvo provider will recommend the approach that best matches your hormonal profile, symptoms, and life goals — and will adjust the protocol over time as your needs evolve.
Explore Luvo’s testosterone medication, Enclomiphene, and Gonadorelin options, or visit the full testosterone program page.
Ask most men on testosterone replacement therapy about fertility preservation and you’ll get a blank look. Ask their providers, and you might get a shrug. The reality is that many TRT protocols — especially those from high-volume telehealth clinics — prescribe testosterone without addressing one of its most significant consequences: suppression of the body’s own reproductive signaling.
When you take exogenous testosterone, your pituitary gland reduces production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Without LH, the testes reduce their own testosterone production. Without FSH, sperm production declines. For some men, this means testicular atrophy and near-zero sperm counts within months of starting TRT.
Gonadorelin is the solution to this problem, and it’s a core component of Luvo’s testosterone program. Here’s why it matters.
Gonadorelin is a synthetic analog of gonadotropin-releasing hormone (GnRH) — the hormone naturally produced by the hypothalamus to signal the pituitary gland. When administered in pulsatile fashion (mimicking the body’s natural release pattern), Gonadorelin stimulates the pituitary to produce LH and FSH.
This is significant during TRT because exogenous testosterone suppresses GnRH from the hypothalamus. The pituitary, receiving no GnRH signal, stops producing LH and FSH. Gonadorelin replaces this missing signal, keeping the pituitary active and maintaining downstream gonadal function.
The result is that the testes continue to produce sperm and contribute their own testosterone, even while exogenous testosterone is being administered. Testicular volume is maintained, and the HPG axis remains functional rather than being completely suppressed.
This mechanism makes Gonadorelin fundamentally different from hCG (human chorionic gonadotropin), which was historically used for this purpose. While hCG mimics LH directly at the testicular level, Gonadorelin works upstream at the pituitary — preserving the entire signaling cascade rather than just one step of it.
Many men starting TRT in their 30s or 40s say they’re “done having kids” or “not planning on it.” While that may be true today, life circumstances change. Relationships change. Decisions that seemed permanent at 35 look different at 42.
Beyond future fertility, there are other reasons to maintain testicular function during TRT.
Testicular atrophy is cosmetically and psychologically significant for many men. The reduction in testicular size that occurs with unsupported TRT is noticeable and can affect self-image and confidence — ironic for a therapy meant to improve exactly those things.
Intratesticular testosterone production contributes to local tissue health beyond just sperm production. The testes produce hormones and signaling molecules that support the broader reproductive system.
HPG axis preservation makes it easier to discontinue TRT if you ever choose to. Without Gonadorelin, prolonged TRT can deeply suppress the HPG axis, making recovery of natural testosterone production difficult and prolonged. With Gonadorelin maintaining pituitary function, the transition off TRT is smoother.
Luvo’s program includes Gonadorelin as a standard consideration for men on TRT precisely because these benefits extend far beyond just fertility.
Luvo’s testosterone program offers Gonadorelin as a key adjunct therapy for men on TRT. The typical protocol involves subcutaneous injection administered multiple times per week, timed to provide the pulsatile stimulation the pituitary needs.
Your Luvo provider determines the appropriate Gonadorelin protocol based on your specific situation, including your age, fertility goals, baseline hormonal status, and the testosterone dose you’re receiving.
The combination of testosterone medication and Gonadorelin gives you the benefits of testosterone optimization without sacrificing reproductive function that competitors rarely offer as an integrated protocol.
For men who want to optimize testosterone without exogenous testosterone at all, Gonadorelin can also be used alongside Enclomiphene for a fully endogenous approach that stimulates the body’s own production from both the pituitary and hypothalamic levels.
Learn more about Gonadorelin at Luvo, or explore the complete testosterone program.
Is Gonadorelin the same as hCG? No. Gonadorelin is a GnRH analog that works at the pituitary level, while hCG mimics LH at the testicular level. Gonadorelin preserves the full HPG signaling cascade, which many clinicians consider a more physiological approach. Additionally, hCG has faced supply and regulatory challenges in recent years, making Gonadorelin an increasingly preferred alternative.
Does Gonadorelin have side effects? Side effects are generally mild. Injection-site reactions are the most common. Some men experience mild headaches or temporary discomfort at the injection site. Serious adverse effects are rare at the doses used for fertility preservation.
Can Gonadorelin fully prevent fertility loss on TRT? While no intervention provides a 100% guarantee, Gonadorelin significantly mitigates the suppressive effects of TRT on sperm production. Most men maintain meaningful sperm counts when Gonadorelin is used consistently alongside TRT.
How long do I need to take Gonadorelin? Typically, for as long as you’re on TRT and want to maintain testicular function and fertility potential. Your Luvo provider will guide this decision based on your evolving goals and clinical status.
Here’s the uncomfortable truth about traditional testosterone replacement therapy: it works brilliantly for raising testosterone levels, but it effectively shuts down your body’s own production. For men who aren’t concerned about fertility, this trade-off is often acceptable. But for men in their 20s, 30s, or early 40s who may want to father children — now or in the future — it creates a genuine dilemma.
Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis. When the body detects sufficient testosterone from an external source, it stops sending the signals (LH and FSH) that tell the testes to produce both testosterone and sperm. The result can be dramatically reduced sperm counts — sometimes to zero.
Enclomiphene solves this problem. It boosts testosterone by working with your body’s own production system rather than replacing it — and it’s one of the key medications in Luvo’s testosterone program.
Enclomiphene is the trans-isomer of clomiphene citrate, a medication that has been used in fertility medicine for decades. What makes Enclomiphene special is its targeted mechanism of action.
In the male hormonal system, the hypothalamus monitors testosterone levels via estrogen signaling. When estrogen (converted from testosterone via aromatase) reaches certain levels, it tells the hypothalamus to reduce GnRH (gonadotropin-releasing hormone) output. This reduces LH and FSH from the pituitary, which in turn reduces testicular testosterone production. It’s a negative feedback loop.
Enclomiphene works by selectively blocking estrogen receptors in the hypothalamus. The hypothalamus, now “blind” to estrogen feedback, interprets the situation as low testosterone and responds by increasing GnRH output. This stimulates the pituitary to release more LH and FSH, which stimulates the testes to produce more testosterone and maintain sperm production.
The result is elevated testosterone through your body’s own machinery, with fully preserved — and often enhanced — fertility. Your testes stay active, your sperm production continues, and your HPG axis remains functional.
If you’ve researched testosterone optimization, you may have encountered clomiphene citrate (Clomid). Clomiphene is a mixture of two isomers: enclomiphene (the trans-isomer) and zuclomiphene (the cis-isomer). They have very different properties.
Enclomiphene is the therapeutically active isomer responsible for the testosterone-boosting effects. It has a relatively short half-life and clean pharmacological action on estrogen receptors in the hypothalamus.
Zuclomiphene, by contrast, has estrogenic activity in some tissues and a much longer half-life, meaning it accumulates with repeated dosing. This accumulation is believed to be responsible for many of the side effects associated with clomiphene citrate, including visual disturbances, mood changes, and paradoxical estrogenic effects.
By using pure Enclomiphene rather than mixed clomiphene, Luvo’s program delivers the testosterone-boosting benefit without the baggage of zuclomiphene accumulation. This is a meaningful clinical advantage that many competitors either don’t offer or don’t explain.
Enclomiphene is particularly well-suited for several patient profiles.
Younger men with low testosterone who want to preserve fertility are the primary candidates. If you’re under 40 and may want children in the future, Enclomiphene offers testosterone optimization without compromising reproductive potential.
Men with secondary hypogonadism — where the problem is inadequate signaling from the pituitary rather than testicular failure — are ideal candidates because Enclomiphene specifically addresses the signaling deficit.
Men who prefer a non-injectable option may find Enclomiphene appealing, as it’s taken orally rather than by injection.
Men who want to try a conservative approach before committing to TRT can use Enclomiphene as a first step. If it raises testosterone sufficiently and resolves symptoms, TRT may not be necessary.
Enclomiphene is less likely to be sufficient for men with primary hypogonadism (testicular failure) or men with very low testosterone who need the more robust elevation that TRT provides. In these cases, Luvo’s providers may recommend TRT with Gonadorelin to maintain fertility.
Explore Luvo’s Enclomiphene option or the full testosterone program.
Clinical data on Enclomiphene demonstrates consistent testosterone elevation. Studies have shown that Enclomiphene can increase total testosterone by 150–300 ng/dL on average, often bringing men from the low or low-normal range into the mid-to-upper normal range.
Patients typically notice improvements in energy and mood within 2–4 weeks as testosterone levels rise. Libido improvements often follow within 4–8 weeks. Body composition changes develop more gradually over 2–6 months, similar to the timeline with TRT though sometimes more modest depending on the degree of testosterone elevation achieved.
Sperm parameters are maintained or improved throughout treatment — a critical difference from TRT. Some studies have shown increases in sperm concentration and motility during Enclomiphene therapy, making it a dual-purpose treatment for men dealing with both low T and subfertility.
Your Luvo provider will monitor your testosterone levels, symptoms, and response to ensure Enclomiphene is delivering the results you need. If it’s not sufficient, transitioning to TRT with Gonadorelin support remains an option.
